- Home
- MDV vs SCPH Comparison
MDV vs SCPH Comparison
Compare MDV & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDV
- SCPH
- Stock Information
- Founded
- MDV 2015
- SCPH 2013
- Country
- MDV United States
- SCPH United States
- Employees
- MDV N/A
- SCPH N/A
- Industry
- MDV Transportation Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- MDV Consumer Discretionary
- SCPH Health Care
- Exchange
- MDV Nasdaq
- SCPH Nasdaq
- Market Cap
- MDV 147.6M
- SCPH 173.6M
- IPO Year
- MDV 2022
- SCPH 2017
- Fundamental
- Price
- MDV $14.42
- SCPH $5.60
- Analyst Decision
- MDV
- SCPH Strong Buy
- Analyst Count
- MDV 0
- SCPH 3
- Target Price
- MDV N/A
- SCPH $14.00
- AVG Volume (30 Days)
- MDV 109.0K
- SCPH 354.9K
- Earning Date
- MDV 08-07-2025
- SCPH 08-13-2025
- Dividend Yield
- MDV 8.11%
- SCPH N/A
- EPS Growth
- MDV N/A
- SCPH N/A
- EPS
- MDV N/A
- SCPH N/A
- Revenue
- MDV $46,738,000.00
- SCPH $41,982,000.00
- Revenue This Year
- MDV $2.21
- SCPH $108.95
- Revenue Next Year
- MDV $4.45
- SCPH $73.83
- P/E Ratio
- MDV N/A
- SCPH N/A
- Revenue Growth
- MDV N/A
- SCPH 138.10
- 52 Week Low
- MDV $13.62
- SCPH $1.94
- 52 Week High
- MDV $18.11
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- MDV 47.63
- SCPH 75.26
- Support Level
- MDV $14.16
- SCPH $4.31
- Resistance Level
- MDV $14.80
- SCPH $6.28
- Average True Range (ATR)
- MDV 0.25
- SCPH 0.31
- MACD
- MDV 0.00
- SCPH 0.12
- Stochastic Oscillator
- MDV 34.71
- SCPH 71.70
About MDV Modiv Industrial Inc. Class C
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.